On June 30, the Centers for Disease Control and Prevention (CDC) made an unpublicized decision to halt the collection of COVID-19 vaccine adverse event reports through its v-safe system, leaving many puzzled about the motivation behind the move.
Without official announcement or explanation, the v-safe website now carries the message, “Thank you for your participation. Data collection for COVID-19 vaccines concluded on June 30, 2023.” This lack of transparency has led to questions about the CDC’s commitment to open communication.
Originally designed to collect post-vaccination health assessments, v-safe played a crucial role in the CDC’s vaccine safety monitoring. However, obtaining vital safety data from the CDC has proven to be a challenging process, requiring legal intervention.
The obtained data strongly suggest that a significant number of individuals experienced adverse events following COVID-19 vaccination. Surprisingly, the CDC responded by attempting to suppress this information, raising concerns about the push for additional booster shots.
Here’s a brief overview of the data: As of September 2022, 10,108,273 individuals reported adverse events using the v-safe app.
- Over 1.2 million individuals faced limitations in performing daily activities post-vaccination.
- 1.3 million experienced absenteeism from school or work.
- 0.8 million sought medical care due to post-vaccination effects.
A staggering 71,299,666 symptoms were reported, including pain, fatigue, headaches, joint pain, and abdominal discomfort, averaging 1.4 symptoms per user. Joint pain, an indicator of inflammation, was notably prevalent.
In a startling revelation, 751,947 individuals required medical attention after receiving a vaccine intended to prevent such medical intervention. Among children under 3 years old, an alarming 65.5% were rushed to urgent care, with 9.1% requiring hospitalization—an astonishing statistic given the low risk of severe COVID-19 for this demographic.
While v-safe’s cessation prevents the collection of new safety reports, the CDC continues to emphasize the importance of gene therapy shots and ongoing booster doses for individuals aged 6 months and above.
However, reliance on the Vaccine Adverse Event Reporting System (VAERS) remains. It’s noteworthy that both the CDC and the U.S. Food and Drug Administration (FDA) overlook this surveillance system, despite widespread acknowledgment that adverse events reported to VAERS are significantly underreported.
Reporting adverse events now involves a laborious process, rather than the user-friendly v-safe app. This change implies that new reports may face challenges in gaining the attention they deserve.
Dr. David Gortler, an expert in drug safety, expressed concern about this unprecedented halt in safety data collection, particularly in the context of mRNA technology’s relative novelty and unknown long-term effects.
The CDC’s continued emphasis on tracking falls, disease infections, and minor incidents, while silencing vaccine-related adverse events, raises questions about its priorities in public health reporting.